Project Grant R03AI182814
Award Date
8/1/25
Completion Date
7/31/27
Dollars Obligated
$149K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $438,038 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Regents of the University of California, Berkeley to conduct research on the regulation of infectious spore formation in the fungal pathogen Coccidioides posadasii. The project aims to use experimental and computational genomic approaches to study how Coccidioides, the causative agent of Valley Fever, preferentially...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research by Virginia Commonwealth University (VCU) to investigate how the intracellular bacterial pathogen Anaplasma phagocytophilum exploits the host cell process of regulated exocytosis for its own release and dissemination. The $436,144 award, granted on September 20, 2024, will fund a 3-year research project to examine the role of...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $216,068 to the University of Alabama at Birmingham (UAB) to study the role of the PRP protease in the ribosome function of the pathogen Streptococcus pneumoniae. The key objectives are to define how PRP and cleavage of the L27 ribosomal protein impact ribosome assembly and activity, as well as examine the...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to elucidate the molecular mechanisms of the high temperature requirement A (HtrA) serine protease in the pathogenic bacterium Streptococcus pneumoniae. The $189,150 award to the University of Colorado-Denver will fund a 2-year study to investigate the structural rearrangements and dynamics of the S....
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $390,000 Project Grant under the Allergy and Infectious Diseases Research (CFDA 93.855) program to the University of Colorado-Denver. The 5-year grant, which commenced on May 2, 2025, supports research to investigate the molecular basis of how the bacterial pathogen Staphylococcus aureus uses its unique serine protease-like (Spl) enzymes, particularly the Spl B variant, to manipulate host cell processes during infection....
The University of Georgia Research Foundation was awarded a $540,193 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The 12-month award, effective August 22, 2023, supports research to investigate the role of calcium-binding proteins and other secretory pathway components in the exocytosis of organelles critical for the invasion and egress of the malaria parasite Plasmodium falciparum...
The Scripps Research Institute was awarded a $779,915 Project Grant by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The 5-year grant, effective May 5, 2025, will support research to investigate the chromatin remodeling functions of polyphosphate condensates in the opportunistic pathogen Pseudomonas aeruginosa. The project aims to define the relationship between polyphosphate, a stress-responsive...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $569,210 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Colorado Boulder. The grant will fund research to structurally and functionally characterize three key proteins responsible for resistance to cationic antimicrobial peptides (CAMPs) and the antibiotic colistin in gram-negative bacteria. The research aims to close knowledge gaps around the biochemical...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $410,497 to the University of California, Santa Barbara to conduct research on a novel effector delivery mechanism used by Bordetella bacteria to translocate toxic effector domains directly into host cells. The project aims to determine if the bacterial adhesin protein FHAL functions as a contact-dependent effector delivery system,...
This Project Grant award of $222,750 from the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 - Allergy and Infectious Diseases Research, will support research on the role of the Fc fragment of IgG binding protein (FcGBP) in the intestinal mucus layer and its impact on gut microbiota composition. The primary goals are to determine how FcGBP contributes to the glycosylation and sialylation of the colon mucus layer, and how this affects the abundance of specific...